| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 645 | 38.827 | 29.505 | 25.936 | 51.181 | 42.769 | - |
| Total Income - EUR | - | - | - | 645 | 38.827 | 33.621 | 33.759 | 51.236 | 96.176 | - |
| Total Expenses - EUR | - | - | - | 26 | 34.606 | 23.137 | 21.199 | 38.434 | 90.695 | - |
| Gross Profit/Loss - EUR | - | - | - | 618 | 4.221 | 10.484 | 12.560 | 12.802 | 5.481 | - |
| Net Profit/Loss - EUR | - | - | - | 599 | 3.833 | 10.189 | 12.300 | 12.300 | 5.061 | - |
| Employees | - | - | - | 0 | 1 | 2 | 1 | 1 | 2 | - |
Check the financial reports for the company - Medaventis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 356.009 | - |
| Current Assets | - | - | - | 661 | 23.616 | 29.120 | 39.411 | 246.033 | 233.617 | - |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 465 | 8.657 | - |
| Receivables | - | - | - | 0 | 17.058 | 24.466 | 31.274 | 240.314 | 208.574 | - |
| Cash | - | - | - | 661 | 6.558 | 4.653 | 7.665 | 5.254 | 16.386 | - |
| Shareholders Funds | - | - | - | 642 | 4.462 | 14.567 | 26.544 | 26.234 | 31.216 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 19 | 19.153 | 14.553 | 12.866 | 33.849 | 422.337 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 185.949 | 136.073 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6202 - 6202" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Medaventis S.r.l.